Ocular Side Effects of Aromatase Inhibitor Endocrine Therapy in Breast Cancer - A Review

被引:9
|
作者
Serban, Dragos [1 ,2 ]
Costea, Daniel Ovidiu [3 ,4 ]
Zgura, Anca [5 ,6 ]
Tudosie, Mihail Silviu [7 ,8 ]
Dascalu, Ana Maria [9 ,10 ]
Gangura, Gabriel Andrei [1 ,11 ]
Smarandache, Catalin Gabriel [1 ,2 ]
Sabau, Alexandru Dan [12 ,13 ]
Tudor, Corneliu [2 ]
Faur, Mihai [12 ,13 ]
Costea, Andreea Cristina [14 ]
Stana, Daniela [10 ]
Balasescu, Simona Andreea [2 ]
Tribus, Laura Carina [15 ,16 ]
Tanasescu, Ciprian [12 ,13 ]
机构
[1] Carol DavilaUniv Med & Pharm, Dept Gen Surg, Fac Med, Bucharest, Romania
[2] Emergency Univ Hosp, Dept Surg Emergency 4, Bucharest, Romania
[3] Ovidius Univ, Fac Med, Dept Clin Surg Disciplines 1, Constanta, Romania
[4] Emergency Cty Hosp, Surg Dept 1, Constanta, Romania
[5] Carol DavilaUniv Med & Pharm, Fac Med, Dept Oncol Radiol & Hematol, Bucharest, Romania
[6] Inst Oncol Prof Dr Alexandru Trestioreanu, Dept Oncol Radiotherapy, Bucharest, Romania
[7] Carol Davila Univ Med & Pharm, Fac Med, Dept Orthopedia & Intens Care, Bucharest, Romania
[8] Clin Emergency Hosp, ICU Toxicol 2, Bucharest, Romania
[9] Carol Davila Univ Med & Pharm, Fac Med, Dept ENT Ophthalmol, Bucharest, Romania
[10] Emergency Univ Hosp, Ophthalmol Dept, Bucharest, Romania
[11] Emergency Univ Hosp, Dept Surg 2, Bucharest, Romania
[12] Lucian Blaga Univ, Fac Med, Surg Clin Dept, Sibiu, Romania
[13] Sibiu Cty Emergency Clin Hosp, Dept Surg, Sibiu, Romania
[14] Diaverum Clin, Nephrol & Dialysis Dept, Constanta, Romania
[15] Carol Davila Univ Med & Pharm, Dept Internal Med Gastroenterol, Fac Med, Bucharest, Romania
[16] Emergency Univ Hosp Bucharest, Gastroenterol Dept, Bucharest, Romania
来源
IN VIVO | 2022年 / 36卷 / 01期
关键词
Breast cancer; endocrine therapy; aromatase inhibitors; ocular side-effects; dry eye; anastrozole; review; DRY-EYE SYNDROME; POSTMENOPAUSAL WOMEN; ADJUVANT TREATMENT; TAMOXIFEN THERAPY; RANDOMIZED-TRIAL; SURFACE DISEASE; ANASTROZOLE; ESTROGEN; LETROZOLE; EXEMESTANE;
D O I
10.21873/invivo.12674
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
in patients with breast cancer. Materials and Methods: A comprehensive search was performed on PubMed, Web of Science and Google scholar. Results: After duplication removal, 14 clinical studies and 5 case reports, published between 2008 and 2021, were identified. Most frequently, AI treatment resulted in minor to moderate dry eye symptoms. "De novo" onset of Sjogren syndrome during AI therapy was also reported. Retinal and optic nerve side effects varied from mild, subclinical anatomic and functional impairment to severe decreased vision, secondary to hemi-central retinal artery occlusion, bilateral optic neuritis or uveitis with bilateral macular edema. Conclusion: Visual disturbances encountered during AI treatment may be underestimated. Ophthalmic screening is important for early detection and appropriate treatment.
引用
收藏
页码:40 / 48
页数:9
相关论文
共 50 条
  • [41] Aromatase inhibitor therapy and hair loss among breast cancer survivors
    Lisa Gallicchio
    Carla Calhoun
    Kathy J. Helzlsouer
    Breast Cancer Research and Treatment, 2013, 142 : 435 - 443
  • [42] Is Adjuvant Aromatase Inhibitor Therapy expanded? Breast Cancer in the Early Stages
    不详
    GYNAKOLOGE, 2016, 49 (09): : 636 - 636
  • [43] The immunomodulatory effects of endocrine therapy in breast cancer
    Huanhuan Huang
    Jun Zhou
    Hailong Chen
    Jiaxin Li
    Chao Zhang
    Xia Jiang
    Chao Ni
    Journal of Experimental & Clinical Cancer Research, 40
  • [44] The immunomodulatory effects of endocrine therapy in breast cancer
    Huang, Huanhuan
    Zhou, Jun
    Chen, Hailong
    Li, Jiaxin
    Zhang, Chao
    Jiang, Xia
    Ni, Chao
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2021, 40 (01)
  • [45] Effects of Endocrine Therapy on Cognitive Function in Patients with Breast Cancer: A Comprehensive Review
    Haggstrom, Lucy R.
    Vardy, Janette L.
    Carson, Emma-Kate
    Segara, Davendra
    Lim, Elgene
    Kiely, Belinda E.
    CANCERS, 2022, 14 (04)
  • [46] Review of neurological side effects associated with checkpoint inhibitor therapy in cancer patients
    Chintalacheruvu, Lakshmi Manogna
    Naha, Kushal
    Chilluru, Vamsi Krishna
    Doll, Donald C.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (05)
  • [47] Endocrine and anti-tumour effects in breast cancer patients treated neo-adjuvantly with the aromatase inhibitor, letrozole
    Miller, WR
    Dixon, JM
    Telford, J
    Marson, L
    Bellamy, C
    Kurian, K
    MacFarlane, L
    Anderson, TJ
    BRITISH JOURNAL OF CANCER, 1999, 80 : 104 - 104
  • [48] Side Effects and Its Management in Adjuvant Endocrine Therapy for Breast Cancer: A Matter of Communication and Counseling
    Johnsson, Aina
    Fugl-Meyer, Kerstin
    Bordas, Pal
    ahman, Janet
    Von Wachenfeldt, Anna
    BREAST CANCER-BASIC AND CLINICAL RESEARCH, 2023, 17
  • [49] Adjuvant endocrine therapy side-effects among postmenopausal breast cancer patients in Malaysia
    Choo S.B.
    Saifulbahri A.
    Zullkifli S.N.
    Fadzil M.L.
    Redzuan A.M.
    Abdullah N.
    Bustamam R.S.A.
    Ahmad H.Z.
    Shah N.M.
    Climacteric, 2019, 22 (02): : 175 - 181
  • [50] Therapeutic effects of the aromatase inhibitor fadrozole hydrochloride in advanced breast cancer
    Bonnefoi, HR
    Smith, IE
    Dowsett, M
    Trunet, PF
    Houston, SJ
    daLuz, RJ
    Rubens, RD
    Coombes, RC
    Powles, TJ
    BRITISH JOURNAL OF CANCER, 1996, 73 (04) : 539 - 542